Skip to content
★ Sign in to follow
ZS

Zachariah Serber

Directeur Scientifique
Zymergen Inc.
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€242k

Latest filing published 19 Oct 2022 for Zymergen Inc..

Filing timeline

BuySale
Zachariah Serber

Insider track record

Disclosed buys
0
Disclosed sells
13

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Zachariah Serber: trading record in brief

Zachariah Serber, listed as senior executive, appears in our data through filings on Zymergen Inc. shares, published by SEC (Form 4). The record holds 18 filings, for trades running from 5 March 2021 to 19 October 2022.

Every open-market trade on record is a sale: 13 sales worth €242k. The rest of the record consists of 1 share grant. In 2022 alone, the filings show no purchases and 13 sales.

The record was last updated on 19 October 2022 with a transaction in Zymergen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Zachariah Serber

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ●
    DirectorExecutivesZymergen Inc.
    0SEC
    2,551,685 sharesCommon StockSEC:0001645842-22-000130:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    7,222 USD26SEC
    3,268 shares@ US$2.212.0% of flowCommon StockSEC:0001645842-22-000122:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    21,251 USD27SEC
    5,435 shares@ US$3.915.7% of flowCommon StockSEC:0001645842-22-000118:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    7,749 USD26SEC
    2,966 shares@ US$2.61252.1% of flowCommon StockSEC:0001645842-22-000109:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    3,698 USD23SEC
    2,797 shares@ US$1.32231.0% of flowCommon StockSEC:0001645842-22-000104:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    4,717 USD23SEC
    2,812 shares@ US$1.67762.0% of flowCommon StockSEC:0001645842-22-000098:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    5,518 USD23SEC
    3,082 shares@ US$1.79032.4% of flowCommon StockSEC:0001645842-22-000063:0
  • ◆
    Chief Science OfficerExecutivesZymergen Inc.
    0SEC
    208,000 shares0Common StockSEC:0001645842-22-000034:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    15,688 USD24SEC
    4,011 shares@ US$3.91136.3% of flowCommon StockSEC:0001645842-22-000023:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    5,568 USD23SEC
    1,424 shares@ US$3.912.2% of flowCommon StockSEC:0001645842-22-000021:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    21,730 USD24SEC
    5,435 shares@ US$3.99818.6% of flowCommon StockSEC:0001645842-22-000017:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    23,529 USD24SEC
    5,435 shares@ US$4.32919.2% of flowCommon StockSEC:0001645842-22-000015:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    27,359 USD24SEC
    5,435 shares@ US$5.033911.0% of flowCommon StockSEC:0001645842-22-000011:0
  • ▼
    Chief Science OfficerExecutivesZymergen Inc.
    103,446 USD27SEC
    21,730 shares@ US$4.760540.9% of flowCommon StockSEC:0001645842-22-000009:0

14 of 14 declarations